(P-1109) A phase 2, randomized, double-blind study of ibezapolstat compared with vancomycin for the treatment of Clostridioides difficile infection: clinical and microbiome evaluation

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

M Jahangir Alam, PhD

Assistant Research Professor
Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA
Houston, Texas, United States
Khurshida Begum, PhD

Research scientist
Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA
Houston, Texas, United States
JM

Jacob McPherson, PharmD

Graduate Student
University of Houston College of Pharmacy
Houston, Texas, United States
Jinhee Jo, PharmD, BCIDP (she/her/hers)

Assistant Professor
University of Houston
Houston, Texas, United States
MS

Michael Silverman, MD

Medical Director
Acurx Pharmaceuticals, LLC
White Plains, NY, United States
Kevin W. Garey, PharmD, MS (he/him/his)

Professor and Chair
University of Houston
Houston, TX, United States